| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |